7.5% Of U.S. Adults Have Long-term Symptoms Of Omicron
Jul 11, 2022
According to a report released on the official website of the US Centers for Disease Control and Prevention (CDC) on June 22, nearly one-fifth of American adults who have reported COVID-19 in the past still have symptoms of the coronavirus.
More than 40 percent of adults in the U.S. report having had COVID-19 in the past, and nearly one in five (19 percent) of them still have symptoms of the coronavirus, according to new data from the Home Pulse Survey. The data were collected by the U.S. Census Bureau from June 1 to June 13 and analyzed by the CDC's National Center for Health Statistics (NCHS). The Home Pulse Survey is a collaborative project between the Census Bureau and the CDC and other federal agencies.
Long-term symptoms of the new coronavirus include fatigue, rapid heartbeat, shortness of breath, cognitive difficulties, chronic pain, paresthesias and muscle weakness. For all U.S. adults, 1 in 13 adults (7.5%) had long-term symptoms of COVID-19, specifically defined as symptoms that persisted for three months or more after first contracting the virus, and that persisted after infection, the CDC analyzed. This symptom was not present before COVID-19.
The CDC also found that older adults are less likely than younger adults to develop COVID-19 symptoms, with nearly three times as many adults 50-59 currently suffering from COVID-19 as adults 80 and older, and 9.4 percent of U.S. Adult women reported long Covid-19 symptoms, compared with only 5.5% of men.
The survey found that nearly 9% of Hispanic adults currently have symptoms of COVID-19, higher than the percentage of non-Hispanic white (7.5%) and black (6.8%) adults, and twice the percentage of non-Hispanic Asian adults (3.7%). times more.
The prevalence of COVID-19 symptoms varies from state to state. The states with the highest proportions of adults with long-term symptoms of COVID-19 are Kentucky (12.7%), Alabama (12.1%), Tennessee and South Dakota (11.6%), and the states with the lowest proportions are Hawaii (4.5%), Maryland (4.7%) and Virginia (5.1%).
France is facing a new wave of COVID-19 infections. French vaccination chief Alain Fischer said on Wednesday that new cases had hit an almost two-month peak a day earlier, surpassing 95,000, Reuters reported. The pandemic has surged again in the country, he said, in favor of reinstating the mandatory wearing of masks on public transport.
Other European countries, notably Portugal, also saw growth due to the new Omicron subvariants BA.4 and BA.5, which according to the European Centre for Disease Control and Prevention are likely to become dominant in the region. These variants do not appear to have a higher risk of severe disease than other forms of Omicron, but they are more contagious than the latter and can lead to increased hospitalizations and deaths, according to the European Centre for Disease Control and Prevention.
New infections in France have been rising steadily since the end of May, nearly tripling the seven-day average of daily new cases from 17,705 on May 27 to 50,402 on Tuesday.
Moderna's coronavirus variant vaccine and traditional Chinese medicine Wecistanche will be ready for anti-covid supplements shipment in August, Chief Executive Stephane Bancel told Reuters on Wednesday. "We're targeting August at the earliest, because we'll be submitting all the data in June, and hopefully within the August time frame, the vaccine will be authorized," Bancel said.
"We can start shipping in August. It might be September in some countries, but it will really be a regulatory decision. The bottleneck now is regulation," he said.
From the perspective of the global Covid 19 epidemic, as of June 22, 2022, according to real-time data from Johns Hopkins University in the United States, the cumulative number of confirmed cases in the world exceeded 541 million, and the number of deaths exceeded 6.323 million, of which the cumulative number of confirmed cases in the United States exceeded 86.636 million The number of deaths exceeded 1.014 million, ranking first in the cumulative number of confirmed cases. In the past 28 days, the regions with the most reported cases were the United States, Taiwan, and Germany, with 2.93 million, 1.918 million, and 1.295 million confirmed cases of the new crown reported in the three places, respectively.
In terms of the domestic epidemic situation, from 0:00 to 15:00 on June 22, 3 new cases of local new coronary pneumonia virus infection were added in Beijing, all of whom were social screeners. This is the fourth consecutive day since June 19 that new social screenings of infected people have occurred after Beijing reported that the social status had been cleared. The 3 new cases of social infection were all in the Economic Development Zone, and the clinical classification was mild, and one of the infected persons was an 8-year-old student. (See: "Beijing Epidemic Added 3 Socially Infected Persons, Economic Development Zone Launches Three-Day Nucleic Acid Screening")
Since June, the positive rate of influenza virus detection in Guangdong, Jiangxi, Fujian, Hainan and other southern provinces has continued to rise, and the number of influenza patients has increased significantly, which has entered the peak season of summer influenza. However, due to epidemic prevention measures such as wearing masks in recent years, the prevalence of the population has declined, immune protection is lacking, and the batch issuance of vaccines is obviously insufficient.
